Progress in ovarian cancer CURRENT OPINION IN OBSTETRICS & GYNECOLOGY Chen, L., Berek, J. S. 1998; 10 (1): 51-56


The management of advanced ovarian cancer relies on appropriate surgical cytoreduction in conjunction with appropriate adjuvant chemotherapy. In the past year several studies have continued to support aggressive cytoreduction at the initial operation, including for stage IV disease, as well as in a second-look setting. Ongoing research has identified several agents active in ovarian cancer, yet the optimal first-line regimen has yet to be developed.

View details for Web of Science ID 000071663600010

View details for PubMedID 9484630